Great news regarding royalties and the milestone payment to be received in March 2014 - "In addition to royalties, Acrux will receive a milestone payment of US$25 million in March 2014 as the worldwide net sales of Axiron in the 2013 calendar year have now exceeded US$100 million, unless there is a material event resulting in a product recall". But am a little perplexed as to the last bit on the statement - is a product recall expected?. Just can't work out why that would be mentioned if all okay - unless it was just to cover all bases in the event of...Still don't make sense to me - sales have greatly exceeded target amount. Be interesting to see now: 1) how bonuses/incentives are based on this; and 2) what the recent substantial SH's will do after taking the tax free dividend next year. Oh well waiting for March 2014 dividend announcement now AND hopefully other good news regarding pipeline projects (yeah I know Scouse don't hold my breath:-).
- Forums
- ASX - By Stock
- ACR
- testosterone in spotlight
ACR
acrux limited
Add to My Watchlist
6.25%
!
1.7¢

testosterone in spotlight, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $6.931M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.6¢ | $6.279K | 376.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 741559 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 193057 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 741559 | 0.016 |
6 | 1259314 | 0.015 |
3 | 420000 | 0.014 |
2 | 397000 | 0.013 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 153057 | 1 |
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 50000 | 1 |
0.021 | 203466 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online